Tag: Human Papillomavirus (HPV)
Nonpediatric Specialties Face Smaller Return Margins for HPV Vaccine Costs
Net returns from HPV vaccine cost reimbursements lowest for family physicians, highest for pediatricians
More CIN2+ Detection Seen With HPV Catch-Up Screening in Women Aged ≥65
Catch-up HPV screening linked to significantly higher CIN2+ detection among women invited for screening by clinician-based or self-sampling
Sample-to-Answer, Point-of-Care HPV DNA Test Feasible
Test requires six user steps and gives answer in 45 minutes
Vaginal HPV Detected in About 40 Percent of Pregnant Women
Perinatal transmission occurred infrequently; no infections detected at birth persisted at age 6 months
More Parents Citing Safety as Reason for HPV Vaccine Hesitancy
2010 to 2018 saw 15.6 percent annual increase in proportion of parents citing 'safety or side effects' as reason for hesitancy
HPV Self-Collection Kits Increase Uptake of Cervical Cancer Screening
Mailed HPV self-collection kits with appointment-scheduling assistance leads to greater uptake of screening in underscreened women
Young Cancer Survivors Have Increased Risk for HPV-Linked Subsequent Cancer
Significantly increased risk seen for any HPV-associated subsequent malignant neoplasms and oropharyngeal neoplasms
AACR: Awareness That HPV Causes Cancer Is Ebbing Among Americans
Furthermore, U.S. vaccination rates for preteens and teens are well below recommended goals
Mailed Human Papillomavirus Self-Sampling Kits Are Cost-Effective
Findings show it is an economically efficient outreach strategy for increasing cervical cancer screening rates
HPV Vaccine Refusal Explored Among Cancer Survivors
Most of the cancer survivors who refused participation in a trial of the vaccine did so for vaccine-related concerns
